A sermorelin reconstitution calculator calculates the exact concentration of reconstituted GHRH(1-29) based on lyophilized peptide mass and diluent volume. By dividing total vial mass by added solvent volume, researchers establish precise microgram-per-milliliter metrics essential for reproducible in vitro and animal models. Explore the complete mathematical framework, solvent dynamics, and chemical handling guidelines below.
A sermorelin reconstitution calculator calculates the exact concentration of reconstituted GHRH(1-29) based on lyophilized peptide mass and diluent volume. By dividing total vial mass by added solvent volume, researchers establish precise microgram-per-milliliter metrics essential for reproducible in vitro and animal models. Explore the complete mathematical framework, solvent dynamics, and chemical handling guidelines below.
In laboratory research, calculating the precise concentration of reconstituted peptides is essential for maintaining quantitative accuracy and experimental reproducibility. Sermorelin, a synthetic 29-amino acid peptide representing the active N-terminal segment of endogenous growth hormone-releasing hormone (GHRH 1-29), is typically delivered as a lyophilized (freeze-dried) powder. Because lyophilized cakes vary in density and volume, reconstituting the compound requires precise mathematical formulas rather than visual estimation.
The fundamental formula governing peptide reconstitution is C = M / V, where C represents the final concentration, M represents the total mass of the peptide in milligrams (mg) or micrograms (mcg), and V represents the volume of diluent added in milliliters (mL). For example, if a investigator reconstitutes a Sermorelin 5mg vial using 2.5 mL of bacteriostatic water, the resulting solution concentration is calculated as 5 mg / 2.5 mL = 2.0 mg/mL (or 2,000 mcg/mL).
When performing micro-volume calculations for cellular assays or micro-dosing protocols in animal models, converting milligrams to micrograms is standard practice. One milligram equals 1,000 micrograms. Therefore, extracting 0.1 mL (100 microliters) from a 2,000 mcg/mL reconstituted solution delivers exactly 200 mcg of active compound. Utilizing a dedicated sermorelin reconstitution calculator reduces manual calculation errors, preventing misdosing in high-throughput preclinical assays.
Sermorelin acetate (CAS 86168-78-7) is a synthesized polypeptide containing the specific sequence H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2. It corresponds directly to the functional amino-terminal domain of naturally occurring human GHRH, which spans 44 amino acids. Structural research demonstrates that the first 29 residues contain the complete biological activity required to select, bind, and activate the growth hormone-releasing hormone receptor (GHRHR).
With a molecular weight of approximately 3,357.9 g/mol, sermorelin features an amidated C-terminus that enhances resistance against rapid enzymatic cleavage by carboxypeptidases in biological media. Despite this C-terminal modification, the peptide exhibits a relatively short terminal elimination half-life in physiological models, typically ranging from 11 to 12 minutes due to rapid enzymatic degradation by dipeptidyl peptidase-IV (DPP-IV), which cleaves the N-terminal Tyr-Ala dipeptide.
Understanding these structural parameters is vital for researchers designing in vitro binding assays or evaluating receptor kinetic profiles. PX1 Research supplies high-purity research compounds across all research peptides, ensuring that molecular weights and chemical structures strictly match theoretical sequences without structural isomers or synthesis byproducts.
In preclinical investigations, sermorelin serves as a foundational reference agonist for characterizing GHRHR signaling cascades in somatotroph cells of the anterior pituitary gland. Upon binding to the extracellular domain of the GHRHR—a seven-transmembrane domain G-protein coupled receptor (GPCR)—sermorelin induces a conformational change that triggers the activation of the stimulatory G-protein subunit (Gs alpha).
In vitro data indicate that this activation stimulates transmembrane adenylate cyclase, resulting in a rapid intracellular rise of cyclic adenosine monophosphate (cAMP). Elevated cAMP levels subsequently activate protein kinase A (PKA), which phosphorylates voltage-gated calcium channels, promoting an influx of extracellular calcium (Ca2+). This intracellular signal drives the exocytosis of pre-stored growth hormone (GH) secretory vesicles into extracellular media.
Furthermore, preclinical rodent studies suggest that sermorelin activation of the PKA-CREB pathway upregulates Pit-1 gene transcription, supporting both GH synthesis and somatotroph cellular differentiation. Because sermorelin preserves natural feedback inhibition loops mediated by somatostatin (SRIF) and insulin-like growth factor 1 (IGF-1), it acts as an essential model compound for researching physiological, pulsatile growth hormone secretion patterns.
Achieving complete solubilization without degrading fragile peptide chains requires strict adherence to aseptic techniques and controlled physical conditions. Investigators should execute peptide reconstitution within a certified laminar flow hood to maintain sterility.
1. **Solvent Selection**: Select an appropriate diluent based on assay timelines. For short-term single-use in vitro assays, unpreserved Sterile Water for Injection (SWFI) or sterile 0.9% Sodium Chloride is standard. For multi-use laboratory protocols spanning several weeks, Bacteriostatic Water containing 0.9% (9 mg/mL) benzyl alcohol is required to inhibit microbial growth. Review our bacteriostatic water protocols for diluent stability profiles.
2. **Pressure Equalization**: Remove the flip-off plastic cap from the vial and sanitize the rubber stopper with a 70% isopropyl alcohol wipe. Allow the stopper to air dry completely. Draw the precise volume of diluent into a sterile lab syringe. Equalize internal vial pressure by introducing air equal to the target diluent volume before injecting liquid.
3. **Diluent Introduction**: Angle the needle so that the diluent stream flows slowly down the interior glass wall of the vial. Direct liquid impact onto the lyophilized cake should be avoided, as rapid hydrodynamic shear forces can disrupt secondary and tertiary peptide structures.
4. **Dissolution Mechanics**: Allow the liquid to naturally saturate the lyophilized powder. Gently swirl the vial in a circular motion on a flat laboratory workbench. Never shake, vortex, or aggressively agitate reconstituted peptide solutions, as mechanical stress induces peptide aggregation and denaturation.
To customize liquid concentrations for specific cell-culture wells or micro-injection instruments, researchers often perform serial dilutions or adjust initial diluent volumes. The table below outlines standard mathematical outcomes when reconstituting a standard 5 mg (5,000 mcg) vial of lyophilized sermorelin with varying volumes of diluent:
- **1.0 mL Diluent**: Final Concentration = 5.0 mg/mL (5,000 mcg/mL). Each 0.01 mL (1 unit on a standard 100-unit lab syringe) equals 50 mcg.
- **2.0 mL Diluent**: Final Concentration = 2.5 mg/mL (2,500 mcg/mL). Each 0.01 mL equals 25 mcg.
- **2.5 mL Diluent**: Final Concentration = 2.0 mg/mL (2,000 mcg/mL). Each 0.01 mL equals 20 mcg.
- **5.0 mL Diluent**: Final Concentration = 1.0 mg/mL (1,000 mcg/mL). Each 0.01 mL equals 10 mcg.
Selecting the proper concentration depends directly on the volumetric limitations of the target experimental system. For instance, micro-injections in small animal models require higher concentrations (lower fluid volumes) to avoid tissue displacement, whereas cell culture treatments benefit from lower concentrations to allow precise pipetting of sub-microgram quantities.
Sermorelin belongs to a broader class of synthetic GHRH receptor agonists, each engineered with distinct structural modifications that alter metabolic stability, receptor binding affinity, and plasma clearance rates. Understanding these differences allows researchers to select the optimal peptide candidate for specific physiological models.
When comparing GHRH analogs, sermorelin represents the baseline 29-amino acid sequence without structural stabilization. In contrast, CJC-1295 without DAC (also known as Modified GRF 1-29) features four amino acid substitutions (Ala2, Gln8, Ala15, Leu27) designed to resist DPP-IV cleavage, significantly extending its biological half-life in vitro. Another key analog, Tesamorelin, incorporates a trans-3-hexenoyl group attached to the N-terminal tyrosine, creating a highly stable compound specifically evaluated in preclinical models of visceral adiposity and hepatic lipid metabolism. Additionally, investigators frequently evaluate non-peptidic or ghrelin-receptor agonists such as Ipamorelin, which activate growth hormone release through the growth hormone secretagogue receptor (GHS-R1a) rather than the GHRH receptor pathway. Combining GHRHR agonists with GHSR agonists often demonstrates synergistic signaling responses in pituitary tissue models.
Peptide integrity is highly sensitive to storage temperature, light exposure, and solution pH. Lyophilized sermorelin should be stored at -20°C to -80°C for long-term preservation, kept dry and protected from light. Under these desiccated freezer conditions, high-purity sermorelin remains stable for up to 24 months without significant degradation.
Once reconstituted in an aqueous diluent, the thermal stability of sermorelin drops substantially. Unpreserved solutions prepared with sterile water must be used immediately or discarded. Reconstituted solutions prepared with bacteriostatic water containing 0.9% benzyl alcohol remain chemically stable when refrigerated at 2°C to 8°C (36°F to 46°F) for up to 28 days.
Primary degradation pathways for aqueous sermorelin include deamidation at asparagine (Asn8, Asn24) and glutamine (Gln16, Gln25) residues, oxidation at the methionine (Met27) position, and hydrolytic peptide backbone cleavage. Exposing solutions to repeated freeze-thaw cycles breaks down peptide tertiary structures through ice crystal formation; therefore, reconstituted stock solutions intended for long-term multi-assay testing should be aliquoted into single-use micro-centrifuge tubes prior to freezing.
Preclinical data validity depends directly on compound quality. Impurities generated during solid-phase peptide synthesis (SPPS)—such as truncated sequences, deleted amino acid fragments, or residual organic solvents—can alter binding affinity, induce cellular toxicity, or yield false-positive assays.
PX1 Research maintains rigorous quality control standards across all catalog products. Every lot of sermorelin undergoes dual analytical verification:
- **Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC)**: Confirms chemical purity exceeds 98.0%, displaying sharp single-peak chromatographic resolution without structural degradation contaminants.
- **Liquid Chromatography-Mass Spectrometry (LC-MS)**: Verifies exact molecular mass matching theoretical molecular weight specs (3357.9 g/mol), confirming accurate amino acid sequencing.
- **Endotoxin Quantification**: Tested via Limulus Amebocyte Lysate (LAL) assay to ensure bacterial endotoxin levels remain strictly below <0.01 EU/mg, preventing inflammatory responses in sensitive cell lines or animal models.
All products are manufactured in GMP-compliant, USA-based facilities, with lot-specific Certificates of Analysis (COAs) accessible via our research library. Laboratories requiring large-scale allocations can explore custom purity specifications through our bulk lab account services.
When integrating sermorelin into automated high-throughput screening (HTS) or long-term receptor binding studies, maintaining concentration uniformity across multi-well plates is critical. Pipetting error margins compound rapidly when working with highly concentrated stock solutions.
To minimize experimental variance, investigators typically prepare primary stock solutions at a concentration of 1.0 mg/mL (1,000 mcg/mL) using sterile bacteriostatic water. From this stock solution, working dilutions are prepared in culture medium (e.g., DMEM or RPMI-1640) supplemented with 0.1% Bovine Serum Albumin (BSA) or human serum albumin. The addition of a carrier protein prevents low-concentration peptides from non-specifically adhering to plastic microplate surfaces or glass pipette tips.
By utilizing a standardized sermorelin reconstitution calculator framework, research teams ensure seamless protocol handoffs between investigators, establishing standardized quantitative benchmarks across diverse experimental trials.
What is the standard formula used in a sermorelin reconstitution calculator?
The formula is Concentration = Mass / Volume (C = M / V). To find final concentration in mg/mL or mcg/mL, divide the mass of lyophilized sermorelin in the vial (e.g., 5 mg or 5,000 mcg) by the volume of diluent injected (e.g., 2.5 mL), yielding 2.0 mg/mL (2,000 mcg/mL).
Which diluent is recommended for reconstituting Sermorelin for multi-use laboratory protocols?
Bacteriostatic Water containing 0.9% benzyl alcohol is recommended for multi-use protocols because the preservative inhibits bacterial growth, allowing the reconstituted solution to remain stable under refrigeration (2°C–8°C) for up to 28 days.
How does Sermorelin differ structurally from native GHRH?
Native human GHRH consists of 44 amino acids. Sermorelin is a synthetic 29-amino acid truncated analog corresponding to the GHRH(1-29) N-terminal sequence, which contains the complete biological activity required to fully bind and activate the GHRH receptor.
Why should reconstituted sermorelin solutions avoid vigorous shaking?
Shaking or vortexing creates mechanical shear forces and air bubbles that cause peptide denaturation and hydrophobic aggregation, disrupting the native secondary structure and rendering the peptide biologically inactive in assays.
What endotoxin limit is acceptable for high-purity sermorelin in cell culture research?
High-purity research sermorelin should feature an endotoxin level below <0.01 EU/mg as measured by LAL assay. Minimal endotoxin content ensures that cellular models do not experience confounding inflammatory cytokine responses.
How should reconstituted sermorelin stock solutions be stored for long-term use?
Reconstituted stock solutions intended for long-term use beyond 28 days should be aliquoted into single-use polypropylene tubes and stored at -20°C or -80°C to prevent freeze-thaw degradation cycles.
What analytical methods verify sermorelin purity and identity?
Analytical verification requires Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm purity levels (>98%) and Liquid Chromatography-Mass Spectrometry (LC-MS) to verify exact molecular mass and sequence identity.
Can sermorelin be reconstituted in phosphate-buffered saline (PBS)?
Sermorelin can be reconstituted in sterile PBS for immediate, single-day in vitro assays. However, PBS contains no antimicrobial preservatives, so solutions cannot be stored for multi-day protocols without risk of microbial contamination.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.